Papers
4
Total Citations
17
H-Index
2
About
Michael Silver is a researcher focused on advancing perioperative care and pain management in minimally invasive gynecologic and urologic surgery. His work centers on optimizing recovery pathways and reducing opioid reliance through innovative regional anesthesia and targeted drug delivery. Silver’s most impactful contribution, “Rethinking the need for overnight admission after robotic-assisted laparoscopic prostatectomy” (2020, 12 citations), challenges traditional postoperative protocols, advocating for same-day discharge to improve patient throughput and satisfaction. He has also led prospective and randomized trials evaluating novel analgesic techniques: a 2025 study on ultrasound-guided quadratus lumborum blocks for hysterectomy pain (2 citations) and a 2022 randomized controlled trial of liposomal bupivacaine injection for supracervical hysterectomy (2 citations). Earlier, Silver conducted a randomized trial combining vaginal misoprostol with perivascular vasopressin during robotic myomectomy (2019, 1 citation). Though his citation counts are modest, his work is clinically relevant, directly informing surgical practice by testing practical, patient-centered interventions. Silver’s research exemplifies a commitment to evidence-based refinement of minimally invasive procedures, with potential to reduce hospital stays and improve postoperative quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4